News release

Date: 22nd August 2012

Global pharmaceutical regulatory affairs specialist ELC Group increases operational support in Ahmedabad

ELC Group continues Indian expansion with move to new, larger offices in key regional centre

Cambridge, UK, August 22nd 2012 – ELC GROUP, the global pharmaceutical regulatory affairs organisation, today announces that it has established new, larger offices in Ahmedabad, India, to support its continued growth in the region. The new Ahmedabad office will host a growing senior team of regulatory affairs professionals, providing expert support and consultancy across ELC Group’s global service portfolio of specialist regulatory affairs consulting and commercialisation services. The expanded base in Ahmedabad follows ELC Group’s announcement earlier this year of a newly-opened office in Mumbai, located in the world’s largest pharmaceutical hub.

The new Ahmedabad operation is staffed by a highly experienced team of RA experts for pharmaceuticals drugs, plus key business development teams focused on regulatory compliance, medical devices and pharmaceuticals. The new Ahmedabad office is also the centre for ELC Group’s REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) services. From its new location, the expanded REACH support team will continue to deliver EU chemical regulatory compliance services to ELC Group customers worldwide.

To support the growth in customer demand for its services, ELC Group has active plans to expand both its REACH and regulatory affairs teams based in the Ahmedabad office, including the recruitment of medical writers, Medical Device experts and a head of Business Development for the entire South-Asian region. The company is also looking for qualified candidates to support the launch of an interim staffing solutions services capability next year.

Commenting on the opening of the new, larger Ahmedabad office, Marco Rubinstein, CEO of ELC Group said: “The opening of larger offices in Ahmedabad is a key milestone for ELC Group, allowing us to expand our senior RA team and providing a solid base from which to extend the breadth of our service offering to our global customers.” He added: “We count among our customers the biggest pharmaceutical companies in India, and Ahmedabad sits at the centre of India’s huge chemistry industry. This expanded regional presence enables us to provide first-class support for our customers’ projects in Europe, as well as new projects across South Asia, including in fast-growth countries such as Indonesia, Vietnam and Thailand.”

ELC Group helps pharmaceutical clients expedite time-to-market through a broad range of development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialisation services. ELC Group delivers its customised solutions through four core business segments: Regulatory Affairs Services; Medical Devices; EU REACH (Registration, Evaluation and Authorisation of Chemicals) Regulation Services; and Corporate Languages Solutions (Translations, Design, DTP, Localisation).

Press contacts:
Akhil Jain
ELC Group
ajain [at] elc-group [dot] com
Phone: +420 22 491 00 00

Nicky Denovan
EvokedSet PR
nicky[at] evokedset [dot] com
Phone: +44 (0)118 3282782

About ELC Group: (
ELC GROUP is a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries as well as REACH services to the Chemical industry. It helps companies that lack the resource (skills and knowledge) to cost effectively deliver regulatory affairs.

ELC Group provides full-service, multi-lingual consulting and cost-effective solutions to regulatory approvals using experts with in-depth knowledge and experience throughout the world. The team ranges from former FDA investigators to individuals with over 30 years of industry experience with broad capabilities. This includes integrated advanced technologies, regulatory affairs consulting and commercialisation services.

Close This Window